Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

DP Veitch, MW Weiner, PS Aisen, LA Beckett… - Alzheimer's & …, 2019 - Elsevier
Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to
validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite …

Cerebral small vessel disease: neuroimaging markers and clinical implication

X Chen, J Wang, Y Shan, W Cai, S Liu, M Hu, S Liao… - Journal of …, 2019 - Springer
Cerebral small vessel disease (CSVD) is a broad category of cerebrovascular diseases
which primarily affect the perforating arterioles, capillaries and venules with multiple distinct …

Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease

KE McAleese, L Walker, S Graham, ELJ Moya… - Acta …, 2017 - Springer
Cerebral white matter lesions (WML) encompass axonal loss and demyelination, and the
pathogenesis is assumed to be small vessel disease (SVD)-related ischemia. However …

Frontal white matter lesions in Alzheimer's disease are associated with both small vessel disease and AD-associated cortical pathology

KE McAleese, M Miah, S Graham, GM Hadfield… - Acta …, 2021 - Springer
Cerebral white matter lesions (WML) encompass axonal loss and demyelination and are
assumed to be associated with small vessel disease (SVD)-related ischaemia. However, our …

White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease

A Soldan, C Pettigrew, Y Zhu, MC Wang, A Moghekar… - Neurology, 2020 - AAN Enterprises
Objective Recent studies suggest that white matter hyperintensities (WMH) on MRI, which
primarily reflect small vessel cerebrovascular disease, may play a role in the evolution of …

White matter hyperintensities and their relationship to cognition: Effects of segmentation algorithm

MA Tubi, FW Feingold, D Kothapalli, ET Hare, KS King… - Neuroimage, 2020 - Elsevier
White matter hyperintensities (WMHs) are brain white matter lesions that are hyperintense
on fluid attenuated inversion recovery (FLAIR) magnetic resonance imaging (MRI) scans …

Neuropathologic correlates of white matter hyperintensities in a community-based cohort of older adults

K Arfanakis, AM Evia, SE Leurgans… - Journal of …, 2020 - content.iospress.com
Background: The association of white matter hyperintensities (WMH) with age-related
vascular and neurodegenerative pathologies remains incompletely understood. Objective …

White matter hypointensities and hyperintensities have equivalent correlations with age and CSF β‐amyloid in the nondemented elderly

K Wei, T Tran, K Chu, MT Borzage… - Brain and …, 2019 - Wiley Online Library
Abstract Introduction T1‐and T2‐weighted sequences from MRI often provide useful
complementary information about tissue properties. Leukoaraiosis results in signal …

[HTML][HTML] Cerebral amyloid burden is associated with white matter hyperintensity location in specific posterior white matter regions

NA Weaver, T Doeven, F Barkhof, JM Biesbroek… - Neurobiology of …, 2019 - Elsevier
White matter hyperintensities (WMHs) are a common manifestation of cerebral small vessel
disease. WMHs are also frequently observed in patients with familial and sporadic …

White matter hyperintensities are associated with subthreshold amyloid accumulation

A Moscoso, D Rey-Bretal, J Silva-Rodríguez, JM Aldrey… - Neuroimage, 2020 - Elsevier
The association between white matter hyperintensities (WMH) and amyloid accumulation
over time in cognitively normal, amyloid-negative elderly people remains largely …